NRG Energy Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? NRG Energy Inc trades at $107.97 (market cap $22.35B), while Relay Therapeutics Inc. Common Stock trades at $17.88 (market cap $3.82B). The key difference: NRG Energy Inc is far larger — about 5.9× Relay Therapeutics Inc. Common Stock's market cap, and NRG Energy Inc pays a 1.79% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NRG Energy Inc for 63 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| NRG | RLAY | |
|---|---|---|
Market Cap | $22.35B | $3.82B |
Volume | 5,011,942 | 4,332,079 |
Sector | Utilities | Health |
52-Week High | $184.03 | $20.75 |
52-Week Low | $95.23 | $6.03 |
Typical Hold Time | 63 Days | 0 Days |
Enterprise Value | $46.30B | $2.93B |
Dividend Yield | 1.79% | — |
Signals from Pluang's Aura AI — not financial advice
NRG Energy trades at $106.32, down 2.11% today, with a bullish technical signal and strong analyst support. The stock shows mixed earnings performance with recent misses but maintains solid fundamentals including $30.71B revenue and 2.56% net margin. Recent developments include a 1.2 GW Texas data center power project and potential acquisition of a West Virginia coal plant, positioning for growth in energy infrastructure.
Outlook remains positive with 70% analyst buy ratings and $202.90 consensus price target representing 91% upside. Key risks include execution of major capital projects, debt levels at 56.42% of assets, and energy market volatility. The dividend yield of approximately 1.6% provides income support while growth initiatives drive long-term potential.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →